Canada Pension Plan Investment Board
AQST icon

Canada Pension Plan Investment Board’s Aquestive Therapeutics AQST Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-175,000
Closed -$383K – 1386
2020
Q1 		$383K Buy
+175,000
New +$665K ﹤0.01% 1025
2019
Q3 		– Sell
-25,000
Closed -$105K – 1185
2019
Q2 		$105K Buy
+25,000
New +$128K ﹤0.01% 1148

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Canada Pension Plan Investment Board's AQST Position: Q2 2020 in Review

Canada Pension Plan Investment Board sold out of Aquestive Therapeutics (AQST) in Q2 2020, closing a stake of 175,000 shares — an estimated $383K sold.

Canada Pension Plan Investment Board first reported a position in AQST in Q2 2019 and held it in 2 quarters. The position peaked at $383K in Q1 2020. 57 funds tracked by Wall St. Rank hold AQST as of Q2 2020.

  • Canada Pension Plan Investment Board reported no remaining Aquestive Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 175,000 Aquestive Therapeutics shares in Q2 2020, an estimated $383K.
  • Canada Pension Plan Investment Board first reported a position in Aquestive Therapeutics in Q2 2019 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Aquestive Therapeutics position peaked at $383K in Q1 2020.
  • 57 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2020, filed 14 Aug 2020.